News stories about Senomyx (NASDAQ:SNMX) have been trending somewhat positive recently, Accern Sentiment reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Senomyx earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned press coverage about the specialty chemicals company an impact score of 46.0134435163503 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Senomyx (SNMX) traded up $0.03 during mid-day trading on Thursday, hitting $1.39. 61,999 shares of the stock traded hands, compared to its average volume of 108,937. The stock has a market capitalization of $65.95, a price-to-earnings ratio of -5.35 and a beta of 1.39. Senomyx has a 1 year low of $0.56 and a 1 year high of $1.71.
Senomyx (NASDAQ:SNMX) last announced its quarterly earnings results on Thursday, November 2nd. The specialty chemicals company reported ($0.05) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.07) by $0.02. The company had revenue of $5.06 million during the quarter. Senomyx had a negative net margin of 42.97% and a negative return on equity of 75.75%. equities research analysts anticipate that Senomyx will post -0.26 earnings per share for the current year.
Senomyx, Inc is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. It is engaged in the discovery, development and/or commercialization of flavor ingredients through over five programs.
Receive News & Ratings for Senomyx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senomyx and related companies with MarketBeat.com's FREE daily email newsletter.